<DOC>
	<DOC>NCT01895153</DOC>
	<brief_summary>The efficacy of pentosan polysulfate sodium, hydrodistension and combination therapy in patients with bladder pain syndrome.</brief_summary>
	<brief_title>Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Cystitis, Interstitial</mesh_term>
	<mesh_term>Pentosan Sulfuric Polyester</mesh_term>
	<criteria>1. men and women who were over 18 years old and had symptoms over 6 months. 2. 4 or more with an pain visual analogue score 3. 12 or more O'LearySant Intersttial Cystitis questionnaire (ICQ) symptom and problem score and with a pain score and nocturia score of 2 or more. 1. history of hydrodistention,augumentation cystoplasty due to IC/BPS 2. pentosan polysulfate sodium (Elmiron) history over 1 month within 6 months. 3. Women of childbearing potential who were pregnant or nursing 4. mean voided volume lesser than 40ml or over than 400ml. 5. hematuria exceeds 1+ in the urinary dipstick (dipstick) examination. 6. urinary tract infection during runin periods. 7. genitourinary tuberculosis or bladder,urethral and prostate cancer 8. recurrent urinary tract infection 9. history of hystrectomy,midurethral sling,pelvic organ prolapse repair,vaginal delivery or Cesarean section,prostate opreation or treatment etc within 6months. 10. neurologic disease history of cerebral infaction,multiple sclerosis or parkinsonism etc.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>bladder pain syndrome</keyword>
	<keyword>pentosan polysulfate</keyword>
	<keyword>hydrodistension</keyword>
</DOC>